Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Duker Jay S., Chief Executive Officer. Director active across 3 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 20 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €17k. History available since 9 February 2022. The latest transaction was disclosed on 10 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Duker Jay S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Jay S. Duker is the Chief Operating Officer and Board Member of EyePoint Pharmaceuticals, Inc. and Sesen Bio, Inc. In this role, he oversees the operations of both companies and contributes to strategic direction. His experience in the pharmaceutical sector is essential in guiding growth and innovation within these organizations. He plays a key role in decision-making that impacts the performance of the companies.